Abstract
BackgroundProstate cancer is an hormone dependent neoplasia, therefore androgenic inhibition by LHRH agonists is the mainstay of treatment. There are different treatment regimen options: continuous or intermittent in order to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
